Parenteral hydration in patients with advanced cancer: A multicenter, double-blind, placebo-controlled randomized trial

Journal of Clinical Oncology

Volumn 31, Issue 1, 2013, Pages 111-118

  Bruera, Eduardo ^a   Hui, David ^a   Dalal, Shalini ^a   Torres Vigil, Isabel ^a,b   Trumble, Joseph ^c   Roosth, Joseph ^d   Krauter, Susan ^e   Strickland, Carol ^f   Unger, Kenneth ^g   Palmer, J Lynn ^a   Allo, Julio ^a   Frisbee Hume, Susan ^a   Tarleton, Kenneth ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c Odyssey Hospice   (United States)

^d Silverado Hospice   (United States)

^e Houston Hospice   (United States)

^f Christus Visiting Nurse Agency Hospice   (United States)

^g VITAS Innovative Hospice Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NITROGEN; PLACEBO; SODIUM CHLORIDE; UREA;

ADULT; ADVANCED CANCER; AGED; ANXIETY; APPETITE DISORDER; ARTICLE; CANCER PAIN; CANCER PATIENT; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DEHYDRATION ASSESSMENT SCALE; DELIRIUM; DEPRESSION; DOUBLE BLIND PROCEDURE; DROWSINESS; DYSPNEA; EDMONTON SYMPTOM ASSESSMENT SCALE; FATIGUE; FEMALE; FLUID THERAPY; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE; HALLUCINATION; HOSPICE PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEMORIAL DELIRIUM ASSESSMENT SCALE; MULTICENTER STUDY; MYOCLONUS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NURSING DELIRIUM SCREENING SCALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; UNIFIED MYCOCLONUS RATING SCALE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; DEHYDRATION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PARENTERAL NUTRITION; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE; SYMPTOM ASSESSMENT;

EID: 84871795158     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.44.6518     Document Type: Article

References (48)

1. Dalal S, Del Fabbro E, Bruera E: Is there a role for hydration at the end of life? Curr Opin Support Palliat Care 3:72-78, 2009
2. Dalal S, Bruera E: Dehydration in cancer patients: To treat or not to treat. J Support Oncol 2:467-479, 483, 2004
3. Bruera E, Sala R, Rico MA, et al: Effects of parenteral hydration in terminally ill cancer patients: A preliminary study. J Clin Oncol 23:2366-2371, 2005
4. de Stoutz ND, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378-384, 1995
5. Bruera E, Franco JJ, Maltoni M, et al: Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 10:287-291, 1995
6. Morita T, Hyodo I, Yoshimi T, et al: Association between hydration volume and symptoms in terminally ill cancer patients with abdominal malignancies. Ann Oncol 16:640-647, 2005
7. Bruera E, Belzile M, Watanabe S, et al: Volume of hydration in terminal cancer patients. Support Care Cancer 4:147-150, 1996
8. Philip J, Smith WB, Craft P, et al: Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer 6:539-541, 1998
9. Strömgren AS, Groenvold M, Pedersen L, et al: Symptomatology of cancer patients in palliative care: Content validation of self-assessment questionnaires against medical records. Eur J Cancer 38:788-794, 2002
10. Moro C, Brunelli C, Miccinesi G, et al: Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14:30-37, 2006
11. Frucht SJ, Leurgans SE, Hallett M, et al: The Unified Myoclonus Rating Scale. Adv Neurol 89:361-376, 2002
12. Lawlor PG, Nekolaichuk C, Gagnon B, et al: Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: Assessing delirium in advanced cancer. Cancer 88:2859-2867, 2000
13. Sessler CN, Gosnell MS, Grap MJ, et al: The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166:1338-1344, 2002
14. Chester JG, Beth Harrington M, Rudolph JL: Serial administration of a modified Richmond Agitation and Sedation Scale for delirium screening. J Hosp Med 7:450-453, 2012
15. Gaudreau JD, Gagnon P, Harel F, et al: Impact on delirium detection of using a sensitive instrument integrated into clinical practice. Gen Hosp Psychiatry 27:194-199, 2005
16. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
17. Eaton D, Bannister P, Mulley GP, et al: Axillary sweating in clinical assessment of dehydration in ill elderly patients. BMJ 308:1271, 1994
18. Gross CR, Lindquist RD, Woolley AC, et al: Clinical indicators of dehydration severity in elderly patients. J Emerg Med 10:267-274, 1992
19. McGee S, Abernethy WB 3rd, Simel DL: The rational clinical examination. Is this patient hypovolemic? JAMA 281:1022-1029, 1999
20. Redelmeier DA, Guyatt GH, Goldstein RS: Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 49:1215-1219, 1996
21. Fainsinger RL, MacEachern T, Miller MJ, et al: The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 9:298-302, 1994
22. Reiff TR: Water and aging. Clin Geriatr Med 3:403-411, 1987
23. Cohen MZ, Torres-Vigil I, Burbach BE, et al: The meaning of parenteral hydration to family caregivers and patients with advanced cancer receiving hospice care. J Pain Symptom Manage 43:855-865, 2012
24. Bruera E, Roca E, Cedaro L, et al: Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 69:751-754, 1985
25. Bruera E, Moyano JR, Sala R, et al: Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: A randomized controlled trial. J Pain Symptom Manage 28:381-388, 2004
26. Bruera E, Strasser F, Palmer JL, et al: Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: A double-blind, placebo-controlled study. J Clin Oncol 21:129-134, 2003
27. Bruera E, Chadwick S, Brenneis C, et al: Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 71:67-70, 1987
28. Bruera E, El Osta B, Valero V, et al: Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 25:3475-3481, 2007
29. Lawlor PG, Gagnon B, Mancini IL, et al: Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Med 160:786-794, 2000
30. Breitbart W, Gibson C, Tremblay A: The delirium experience: Delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 43:183-194, 2002
31. Namba M, Morita T, Imura C, et al: Terminal delirium: Families' experience. Palliat Med 21:587-594, 2007
32. Morita T, Hirai K, Sakaguchi Y, et al: Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Psychosomatics 45:107-113, 2004
33. Bruera E, Bush SH, Willey J, et al: Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 115:2004-2012, 2009
34. Morita T, Tei Y, Tsunoda J, et al: Increased plasma morphine metabolites in terminally ill cancer patients with delirium: An intra-individual comparison. J Pain Symptom Manage 23:107-113, 2002
35. Lawlor PG: The panorama of opioid-related cognitive dysfunction in patients with cancer: A critical literature appraisal. Cancer 94:1836-1853, 2002
36. Inouye SK, Bogardus ST Jr, Charpentier PA, et al: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340:669-676, 1999
37. Seymour DG, Henschke PJ, Cape RD, et al: Acute confusional states and dementia in the elderly: The role of dehydration/volume depletion, physical illness and age. Age Ageing 9:137-146, 1980
38. Gagnon P, Allard P, Mâsse B, et al: Delirium in terminal cancer: A prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manage 19:412-426, 2000
39. Maddocks I, Somogyi A, Abbott F, et al: Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 12:182-189, 1996
40. Tuma R, DeAngelis LM: Altered mental status in patients with cancer. Arch Neurol 57:1727-1731, 2000
41. National Hospice and Palliative Care Organization (NHPCO): NHPCO Facts and Figures: Hospice Care in America - National Data Set 2010 (ed 2011). Alexandria, VA, NHPCO, January 2012
42. Cerchietti L, Navigante A, Sauri A, et al: Hypodermoclysis for control of dehydration in terminal-stage cancer. Int J Palliat Nurs 6:370-374, 2000
43. Morita T, Tei Y, Tsunoda J, et al: Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manage 22:997-1006, 2001
44. Morita T, Tei Y, Inoue S: Agitated terminal delirium and association with partial opioid substitution and hydration. J Palliat Med 6:557-563, 2003
45. Andrews M, Bell ER, Smith SA, et al: Dehydration in terminally ill patients. Is it appropriate palliative care? Postgrad Med 93:201-203, 206-208, 1993
46. Waller A, Hershkowitz M, Adunsky A: The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients. Am J Hosp Palliat Care 11:22-27, 1994
47. Casarett DJ, Karlawish J, Hirschman KB: Are hospices ready to participate in palliative care research? Results of a national survey. J Palliat Med 5:397-406, 2002
48. Casarett D, Ferrell B, Kirschling J, et al: NHPCO Task Force Statement on the Ethics of Hospice Participation in Research. J Palliat Med 4:441-449, 2001